Bradley Foster & Sargent’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$224K Hold
706
0.01% 305
2019
Q4
$210K Buy
+706
New +$196K 0.01% 346
2019
Q3
Sell
-1,105
Closed -$258K 344
2019
Q2
$258K Sell
1,105
-460
-29% -$106K 0.01% 313
2019
Q1
$370K Sell
1,565
-1,747
-53% -$550K 0.01% 287
2018
Q4
$997K Sell
3,312
-818
-20% -$261K 0.04% 204
2018
Q3
$1.46M Buy
4,130
+98
+2% +$33.7K 0.05% 194
2018
Q2
$1.17M Sell
4,032
-445
-10% -$125K 0.04% 211
2018
Q1
$1.23M Sell
4,477
-100
-2% -$31K 0.05% 202
2017
Q4
$1.46M Buy
4,577
+45
+1% +$14.4K 0.05% 186
2017
Q3
$1.42M Sell
4,532
-77
-2% -$22.8K 0.05% 185
2017
Q2
$1.25M Sell
4,609
-715
-13% -$189K 0.05% 186
2017
Q1
$1.46M Sell
5,324
-2,605
-33% -$737K 0.06% 178
2016
Q4
$2.25M Sell
7,929
-32,488
-80% -$9.63M 0.1% 142
2016
Q3
$12.7M Sell
40,417
-4,173
-9% -$1.24M 0.55% 64
2016
Q2
$10.8M Buy
44,590
+697
+2% +$184K 0.48% 65
2016
Q1
$11.4M Sell
43,893
-591
-1% -$156K 0.53% 63
2015
Q4
$13.6M Buy
44,484
+39,609
+812% +$11.4M 0.62% 55
2015
Q3
$1.42M Buy
4,875
+3,328
+215% +$1.1M 0.07% 164
2015
Q2
$625K Buy
1,547
+134
+9% +$53.8K 0.03% 234
2015
Q1
$597K Buy
+1,413
New +$557K 0.03% 240

Other funds holding BIIB

Bradley Foster & Sargent's BIIB Position: Q1 2020 in Review

Bradley Foster & Sargent held its Biogen (BIIB) position steady in Q1 2020 at 706 shares worth $224K. The position accounts for 0.01% of the portfolio, ranked #305.

Bradley Foster & Sargent first reported a position in BIIB in Q1 2015 and has held it in 20 quarters since. The position peaked at $13.6M in Q4 2015. 1,099 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • Bradley Foster & Sargent held 706 shares of Biogen worth $224K as of Q1 2020.
  • Bradley Foster & Sargent left its Biogen share count unchanged in Q1 2020.
  • Biogen made up 0.01% of Bradley Foster & Sargent's portfolio in Q1 2020, its #305 holding.
  • Bradley Foster & Sargent first reported a position in Biogen in Q1 2015 and has held it in 20 quarters since.
  • Bradley Foster & Sargent's Biogen position peaked at $13.6M in Q4 2015.
  • 1,099 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Bradley Foster & Sargent's 13F filing for Q1 2020, filed 7 May 2020.